Actively Recruiting
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
Led by Rabin Medical Center · Updated on 2025-07-24
106
Participants Needed
2
Research Sites
206 weeks
Total Duration
On this page
Sponsors
R
Rabin Medical Center
Lead Sponsor
S
Sheba Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone stent in patients with MUO. The primary endpoint is stent failure rate. The secondary endpoints are patient comfort, quality of life and overall survival.
CONDITIONS
Official Title
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with malignant ureteral obstruction
You will not qualify if you...
- Ureteral obstruction caused by conditions other than malignancy
- Inability to understand or provide informed consent due to language or other limitations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Rabin Medical Center
Petah Tikva, Israel, 49414
Actively Recruiting
2
Sheba medical center
Ramat Gan, Israel
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here